Skip to main content

Table 1 Demographics and expenditures of patients with/without ESRD who received CABG

From: Hospital costs and prognosis in end-stage renal disease patients receiving coronary artery bypass grafting

  ESRD Non-ESRD P value Absolute standardized difference
N = 48 N = 96
Age (mean ± SD) 62.04 ± 10.04 61.63 ± 11.77 .838 0.0375
39 (%) 1 (2.1) 3 (3.1) .954  
 40–49 6 (12.5) 10 (10.4)  
 50–59 15 (31.3) 29 (30.2)  
 60–69 12 (25.0) 29 (30.2)  
70 14 (29.2) 25 (26.0)  
Sex (%)
 Male 32 (66.7) 66 (68.8) .800 0.0449
 Female 16 (33.3) 30 (31.3)
Comorbidities (%)
 Hypertension 34 (70.8) 62 (64.6) .453 0.1328
 Diabetes 32 (66.7) 69 (71.9) .520 0.1129
 Myocardial infarction 14 (29.2) 31 (32.3) .703 0.0672
 Stroke 15 (31.3) 21 (21.9) .221 0.2139
 Congestive heart failure 28 (58.3) 52 (54.2) .635 0.0827
 Peripheral arterial disease 10 (20.8) 14 (14.6) .343 0.1629
 COPD 8 (16.7) 18 (18.8) .759 0.0549
Expenditure in CABG (mean ± SD)
 ICU use (day) 11.06 ± 12.18 7.24 ± 8.89 .058  
 ICU cost (1000NTD) 28.75 ± 31.80 17.99 ± 21.68 .030  
 Ventilator use (day) 10.21 ± 12.34 6.40 ± 11.05 .064  
 Ventilator cost (1000NTD) 15.99 ± 20.09 10.06 ± 17.73 .074  
 Length of stay (day) 21.47 ± 12.69 17.71 ± 10.07 .094  
 Surgery cost (1000NTD) 565.20 ± 300.31 421.89 ± 247.74 .010  
Mortality (%)
 Perioperative 5 (10.4) 2 (2.1) .028  
 Postoperative 16 (33.3) 11 (11.5) .002  
 Follow-up years (median) 3.10 4.06